Status:
COMPLETED
Efficacy and Safety With Ziprasidone in First-episode Psychosis
Lead Sponsor:
Chonbuk National University Hospital
Collaborating Sponsors:
Pfizer
Conditions:
First Episode Psychosis
Eligibility:
All Genders
14-45 years
Phase:
PHASE4
Brief Summary
The aim of the study is to investigate the efficacy and safety of ziprasidone in patients with first episode psychosis.
Eligibility Criteria
Inclusion
- Patients who meet DSM-IV criteria for first episode schizophrenia, schizophreniform disorder and schizoaffective disorder
Exclusion
- Patients with previously prescribed antipsychotic medication in 2 weeks or more
- patients with substance-induced psychotic disorder, serious suicide attempt, neurological disorder, etc.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT01157559
End Date
May 1 2010
Last Update
July 7 2010
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychiatry, Chonbuk national University Hospital
Jeonju, South Korea
2
Heo psychiatric Hospital
Jeonju, South Korea
3
Jeonju Jesus Hospital
Jeonju, South Korea